Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response-Reference-Cited by-同舟云学术

Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response

Published:2014-01-17 Issue:7 Volume:5 Page:1770-1778
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Salzano Marcella¹²,Vázquez-Cedeira Marta¹²,Sanz-García Marta¹,Valbuena Alberto¹,Blanco Sandra¹,Fernández Isabel F.¹²,Lazo Pedro A.¹²

Affiliation:

1. Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, Salamanca, Spain

2. Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε;Journal of Medicinal Chemistry;2024-05-23

2. Nuclear functions regulated by the VRK1 kinase;Nucleus;2024-05-16

3. Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy;Journal of Molecular Medicine;2024-03-30

4. Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin;Chemico-Biological Interactions;2024-03

5. The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase;Epigenetics & Chromatin;2023-05-13